Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
04/1999
04/29/1999WO1999020238A1 Metal ion-containing oral products with reduced astringency
04/29/1999WO1999020223A2 Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive
04/29/1999CA2306983A1 Methods for treating hypercoagulable states or acquired protein c deficiency
04/29/1999CA2306402A1 Cleansing compositions
04/28/1999EP0911342A1 Novel protein and process for producing the same
04/28/1999EP0911021A2 Methods and compositions for fine lines and/or wrinkles
04/28/1999EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis
04/28/1999EP0910383A1 The use of growth factor modulating compounds
04/28/1999EP0910372A1 Pharmaceutical compositions containing mesembrine and related compounds
04/28/1999EP0910330A1 Hair dye compositions and process
04/28/1999EP0650359B1 Transdermal therapeutic system containing the active substance 17- -oestradiol (anhydrous)
04/22/1999WO1999019300A1 Prostaglandin agonists and their use to treat bone disorders
04/22/1999WO1999018972A1 New improved formulation for treatment of osteoporosis
04/22/1999WO1998052548A3 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions
04/22/1999WO1998045328A3 Compositions and methods for the treatment and diagnosis of breast cancer
04/21/1999EP0909768A2 Process for removing bile salts from a patient and alkylated compositions therefor
04/21/1999CN1043042C Resolution method of alpha-(2,2-dimethylpropionyloxy) ethyl 7-[2-(2-amino-thiazol-4-yl)-2-(2)-hydroxyl-imino-acetamido]-3-(methoxy methyl)-3-cephem-4-carboxylate
04/20/1999US5895654 Streptococcus equi vaccine
04/15/1999WO1999018075A1 Novel dihydronaphthalene compounds and process for producing the same
04/15/1999WO1999017733A1 Oxidation dyeing composition for keratin fibres and dyeing method using said composition
04/15/1999WO1999017731A1 Oxidation dyeing composition for keratin fibres and dyeing method using said composition
04/15/1999WO1999017727A1 Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres
04/15/1999WO1999017726A1 Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres
04/15/1999WO1999017722A1 Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres
04/15/1999WO1999017714A2 Cosmetic compositions containing azelaic acid
04/15/1999WO1999008648A3 Hair conditioner and 2-in-1 conditioning shampoo
04/15/1999WO1999004773A3 Method for inhibiting bone resorption
04/15/1999WO1999004770A3 A pharmaceutical composition active in reducing production of mcp-1 protein
04/15/1999CA2298527A1 Novel dihydronaphthalene compounds and process for producing the same
04/15/1999CA2272457A1 Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres
04/15/1999CA2272456A1 Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres
04/15/1999CA2272454A1 Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres
04/15/1999CA2271987A1 Oxidation dyeing composition for keratin fibres and dyeing method using said composition
04/15/1999CA2271980A1 Oxidation dyeing composition for keratin fibres and dyeing method using said composition
04/14/1999EP0907737A1 Il-6 mutein
04/14/1999EP0907350A2 A barrier cream comprising hexamethylenetetramine or derivative thereof
04/14/1999CN1213970A Method for treating autism
04/14/1999CN1213966A Method for treating bipolar disorder
04/08/1999WO1999016413A1 Nonaerosol shave gel compositions
04/08/1999WO1998056333A9 Aqueous carrier systems for water-insoluble materials
04/08/1999CA2304953A1 Nonaerosol shave gel compositions
04/07/1999EP0906119A1 Method of treatment
04/07/1999EP0906107A1 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
04/07/1999EP0906086A1 Composition
04/06/1999US5892073 Process for preparation of 13-cis-retinoic acid
04/06/1999US5891449 Skin cleaning agents, a process for their production and their use
04/01/1999WO1999015210A2 Bioadhesive compositions and methods for topical administration of active agents
04/01/1999WO1999015142A1 Fluoride dentifrices of enhanced efficacy
03/1999
03/31/1999EP0905136A1 Tetrahydro gamma-carbolines
03/31/1999EP0904092A1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
03/31/1999EP0904087A1 Phosphatidic acid-comprising compositions
03/31/1999EP0794764B1 Topical skin care compositions containing thickened polyol carboxylic acid esters as skin conditioning agents
03/30/1999US5889056 Of nitric oxide synthase; hypotensive agent, antiinflammatory agents, antiarthritic agents
03/30/1999US5889032 Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
03/30/1999US5889025 Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
03/25/1999WO1999014199A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
03/25/1999WO1999014185A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
03/25/1999WO1999013867A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
03/25/1999WO1999013844A1 Hair care compositions comprising optical brighteners which provide uv protection
03/25/1999WO1999013839A1 Conditioning shampoo composition comprising pentaerythritol ester oil
03/25/1999WO1999013838A1 Hair conditioning composition comprising high molecular weight ester oil
03/25/1999WO1999013835A1 Conditioning shampoo composition comprising high molecular weight ester oil
03/25/1999WO1999013828A1 Shampoo compositions comprising optical brighteners and mild surfactant matrix
03/25/1999WO1999013826A1 Hair care compositions comprising polystyrylstilbenes
03/25/1999WO1999013824A1 Hair care compositions comprising bulky optical brighteners
03/25/1999CA2304265A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
03/25/1999CA2304002A1 Conditioning shampoo composition comprising pentaerythritol ester oil
03/25/1999CA2303323A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
03/24/1999EP0902683A1 AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES
03/24/1999EP0673240B1 Stabilized medicinal aerosol solution formulations
03/23/1999US5885596 Methods and compositions for fine lines and/or wrinkles
03/18/1999WO1999012926A1 Tetrahydro gamma-carbolines
03/18/1999WO1999012542A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
03/18/1999WO1998057937A3 Inhibitors of factor xa with a neutral p1 specificity group
03/18/1999DE19740110A1 New hydroxy substituted benzomorphan derivatives
03/18/1999CA2301807A1 Tetrahydro gamma-carbolines
03/17/1999EP0901377A1 Acne treatment
03/17/1999CN1211190A Natural tea for taking off the effects of drink and process for production thereof
03/17/1999CN1211177A Compositions containing an antifungal and a sulfur compound
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883102 Pharmaceutically active compounds
03/16/1999US5882655 Serpulina hyodysenteriae vaccine comprising a hygene mutant
03/16/1999CA2094513C Encapsulated antiperspirant salts and deodorant/ antiperspirants
03/11/1999WO1999011232A1 Oral compositions
03/11/1999WO1998055080A3 Leave-on antimicrobial compositions
03/11/1999CA2300676A1 Oral compositions
03/10/1999EP0735898B1 Vaccines
03/10/1999EP0504372B1 Cosmetic technology
03/09/1999US5880113 Antiproliferative agents, cell differentiation inducers
03/09/1999US5880106 Containing water insoluble antacid buffering composition combined with dihydroxyaluminum alkali metal carbonate or calcium carbonate, optional excipients; improved bioavailability, reduced side effects
03/09/1999US5879659 Images for diagnosis of cardiovascular disorders
03/09/1999US5879412 Compositions and processes for dyeing keratin fibers with an oxidation base, a coupler, a cationic direct dye, and an oxidizing agent
03/04/1999WO1999009949A1 Cleansing compositions
03/04/1999WO1999009948A1 Cleansing compositions
03/04/1999CA2300427A1 Cleansing compositions
03/04/1999CA2300108A1 Cleansing compositions
03/03/1999CN1042299C Preparation method for improved oral preparation of dideoxy purine nucleosides
03/02/1999US5876701 Striped toothpaste stable to color bleeding
02/1999
02/25/1999WO1999009015A1 2-{3-[4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate
02/25/1999WO1999008650A2 Use of ascorbic acid in permanent waving and hair coloring compositions
1 ... 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 ... 295